Associated Factors of Morbidity and Mortality in Emphysematous Pyelonephritis.
DOI:
https://doi.org/10.54212/27068048.v10i1.76Keywords:
Pyelonephritis, Emphysematous, Kidney, Renal abscessAbstract
Emphysematous pyelonephritis is considered a severe clinical condition that compromises the kidney and the patient's health. This pathology should be considered in
case of urinary tract infection associated with serious clinical signs, mainly in diabetics. Therefore, it is of great interest for the institution to have a compilation of the cases that occur, the associated factors in our population, as well as their evolution and management. Materials and methods: the data was obtained retrospectively using access to the clinical records of patients who consulted in the emergency unit of the ISSS General Hospital and were classified as having emphysematous
pyelonephritis between the years 2015 and 2020. Results: 39 patients with emphysematous pyelonephritis were analyzed the most frequent age range was between 50 and 59 years. The female sex predominated with 62%. The risk factor most associated with 36% is Diabetes Mellitus, followed by obesity with 20%; in third place are recurrent urinary tract infections in 14%. Conclusion: the female population is the most likely to develop this pathology associated with factors such as Diabetes. The current trend is to make an early diagnosis and use non-surgical treatment.
Downloads
References
Ozawa M, Ichiyanagi O, Fujita, Naito, Fukuhara H, Suenaga S, Takai, Narisawa, Hosoya, Ishii, Yamanobe, Muto, Suzuki, Nishida, Kato, Tsuchiya. Risk of SOFA Deterioration in Conservative Treatment for Emphysematous Pyelonephritis: Pitfalls of Current Trends in Therapeutics from Multicenter Clinical Experience. Curr Urol. 2019 May 10;12(3):134-141. https://doi.org/10.1159/000489431 DOI: https://doi.org/10.1159/000489431
Punatar, Jadhav, Kumar, Joshi, Sagade. Neutrophil:Lymphocyte Ratio as a Predictive Factor for Success of Nephron-Sparing Procedures in Patients with Emphysematous Pyelonephritis. Perm J. 2019;23:18-044. https://doi.org/10.7812/TPP/18-044 DOI: https://doi.org/10.7812/TPP/18-044
Chia Gonzales S, Pinto Valdivia M, Ramírez Vela RM, Manrique Hurtado H, Rosas Febres M. Factores de riesgo para pielonefritis enfisematosa en pacientes con diabetes mellitus tipo 2. Revista Sociedad Peruana de Medicina Interna 2017. Disponible en: http://revistamedicinainterna.net/index.php/spmi/article/view/82
Muñoz-Lumbreras EG, Michel-Ramírez JM, Gaytán-Murguía M, et al. Pielonefritis enfisematosa: Revisión de la fisiopatología y tratamiento. Rev Mex Urol. 2019;79(1):1-14. Disponible en: https://doi.org/10.48193/revistamexicanadeurologa.v79i1.390 DOI: https://doi.org/10.48193/revistamexicanadeurologa.v79i1.390
https://www.medigraphic.com/cgibin/new/resumen.cgi?IDARTICULO=86804
Campbell-Walsh-Wein, Urology, 2021, 12 edición. Chapter 55 Infections of the Urinary Tract, Philadelphia, EE.UU, Elsevier.
Saadi A1, Ayed H2, Bouzouita A2, Cherif M2, Kerkeni W2, Selmi S2, Ben Slama R2, Derouiche A2, Chebil M2. Results of conservative management of emphysematous pyelonephritis. Nephrol Ther. 2016 Dec;12(7):508-515. https://doi.org/10.1016/j.nephro.2016.05.007 DOI: https://doi.org/10.1016/j.nephro.2016.05.007
Elbaset, Zahran, Hashen, Ghobrial, Elrefaie, Badawy, Shokeir, Ibrahim. Could platelet to leucocytic count ratio (PLR) predict sepsis and clinical outcomes in patients with emphysematous pyelonephritis?. J Infect Chemother. 2019 Oct;25(10):791-796. https://doi.org/10.1016/j.jiac.2019.04.008
Sokhal AK, Kumar M, Purkait B, Jhanwar A, Singh K, Bansal A, Sankhwar S. Emphysematous pyelonephritis: Changing trend of clinical spectrum, pathogenesis, management and outcome. Turk J Urol. 2017 Jun;43(2):202-209. doi: 10.5152/tud.2016.14227. Epub 2017 Jan 27. PMID: 28717547; PMCID: PMC5503442. https://doi.org/10.5152/tud.2016.14227 DOI: https://doi.org/10.5152/tud.2016.14227
Torres-Mercado, León Octavio, García-Padilla, Miguel Ángel, Serrano-Brambila, Eduardo, Maldonado-Alcaraz, Efraín, López-Sámano, Virgilio Augusto, Montoya-Martínez, Guillermo y Moreno-Palacios, Jorge Factores pronósticos de morbimortalidad en pacientes con pielonefritis enfisematosa. Revista Médica del Instituto Mexicano del Seguro Social. 2016;54(2):156-161. [fecha de Consulta 25 de Marzo de 2021]. ISSN: 0443-5117. Disponible en: https://www.redalyc.org/articulo.oa?id=457746954007.
Deoraj S, Zakharious F, Nasim A, Missouris C. Emphysematous pyelonephritis: outcomes of conservative management and literature review. BMJ Case Rep. 2018 Sep 12;2018:bcr2018225931. doi: 10.1136/bcr-2018-225931. PMID: 30209146; PMCID: PMC6144252. https://doi.org/10.1136/bcr-2018-225931 DOI: https://doi.org/10.1136/bcr-2018-225931
Kalathia J, Chipde SS, Agrawal S, Agrawal R. Nephron-sparing surgery in case of emphysematous pyelonephritis. Urol Ann. 2015 Oct-Dec;7(4):504-6. doi: 10.4103/0974-7796.162211. PMID: 26692674; PMCID: PMC4660705. https://doi.org/10.4103/0974-7796.162211 DOI: https://doi.org/10.4103/0974-7796.162211
V. Vishnu Vardhana Reddy, K. Panduranga Rao. A clinical study of emphysematous pyelonephritis. IAIM, 2018; 5(2): 150-159. Disponible en: http://iaimjournal.com/
Elbaset, Zahran, Hashen, Ghobrial, Elrefaie, Badawy, Shokeir, Ibrahim. Could platelet to leucocytic count ratio (PLR) predict sepsis and clinical outcomes in patients with emphysematous pyelonephritis?. J Infect Chemother. 2019 Oct;25(10):791-796. https://doi.org/10.1016/j.jiac.2019.04.008 DOI: https://doi.org/10.1016/j.jiac.2019.04.008
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Judith Rebeca Ramos Guerra, Duncan Benjamín Cunza, Marvin Mejía
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License 4.0 that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
